These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling. Gordon J, Cairns JA, Millsum MJ, Gillis S, Guy GR. Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932 [Abstract] [Full Text] [Related]
17. CD23-mediated cell signalling. Kolb JP, Abadie A, Proschnicka-Chalufour A, de Gramont A, Poggioli J. J Lipid Mediat Cell Signal; 1994 Feb; 9(1):27-35. PubMed ID: 8032713 [Abstract] [Full Text] [Related]
18. Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production in B lymphocytes is reversed on engaging CD40. Katira A, Knox KA, Finney M, Michell RH, Wakelam M, Gordon J. Clin Exp Immunol; 1993 May; 92(2):347-52. PubMed ID: 7683590 [Abstract] [Full Text] [Related]
19. Interleukin-7 modulates CD23 and HLA-DR expression on CD4+ T cells and promotes a Th-2 type citokine profile. Fratazzi C, Carini C. Allergol Immunopathol (Madr); 1997 May; 25(4):189-98. PubMed ID: 9269509 [Abstract] [Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Heine G, Anton K, Henz BM, Worm M. Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570 [Abstract] [Full Text] [Related] Page: [Next] [New Search]